COVID-19 Vaccine: 2 TSX Stocks to Watch

With a potential COVID-19 vaccine in the development pipeline, investors are feeling more positive about the stock market. These are two stocks to watch!

| More on:
healthcare pharma

Image source: Getty Images

Earlier today, American pharmaceutical giant Pfizer announced its COVID-19 vaccine candidate was showing 90% effectiveness in trials. While there’s more testing to be done, this is unquestionably positive news for people everywhere.

While there’s still a ways to go between now and the potential distribution of a vaccine, there’s now some light at the end of the tunnel. So, naturally, this positive sentiment has made its way to the stock market.

With COVID-19 vaccine news in tow, the stock market as a whole has rebounded in a major way. With investors more confident in the economy going forward, many stocks have been taking off.

Today, we’ll look at two TSX stocks Canadian investors can keep an eye on following this important announcement.

Enbridge

Enbridge (TSX:ENB)(NYSE:ENB) is a major Canadian energy distribution company. While the stock has struggled recently, it’s due for a turnaround.

If the economy starts to open up even more with a COVID-19 vaccine, Enbridge is in line to benefit. After all, without much action in the economy there has been much less demand for energy.

Enbridge had a great start to 2020 before being derailed by the pandemic. It traded as high as $57.13 in February and is trading at $37.52 as of this writing.

So, even though it’s been experiencing a near-5% jump today, it still has a long ways to go to even get back to previous levels. With a stronger economy surrounding it, Enbridge could be a prime rebound candidate.

As for its dividend, the payout ratio of 329% certainly isn’t encouraging. It’s possible Enbridge has to cut its dividend sooner than later, but a speedy recovery would go a long way in quelling those fears.

If you’re looking to pick up a solid blue-chip TSX stock with rebound potential in light of a COVID-19 vaccine, Enbridge is a solid choice.

Air Canada

Air Canada (TSX:AC) is Canada’s largest airline and as such has been in a peculiar position as of late. Its stock has been down around 70% on the year at various points recently.

Of course, some tighter new restrictions haven’t helped the case for Air Canada either. However, the government has also been in talks for some sort of stimulus relief for airlines as well.

Now, with a COVID-19 vaccine on the horizon, things could be looking up for Air Canada. This TSX stock would stand to benefit greatly from a more active and open economy.

It’s clear the stock market has hope for Air Canada, as it’s up 24.40% today as of this writing. That’s a massive bump and is directly related to Pfizer’s big announcement.

Of course, a full-fledged recovery could take a fair amount of time and require more good news. However, TSX investors looking for a rebounding stock definitely won’t want to miss Air Canada’s liftoff.

COVID-19 vaccine possibly ahead

With Pfizer’s major breakthrough announced today, there is serious hope for an imminent COVID-19 vaccine. This is fantastic news for everyone’s safety and well-being.

For Canadian investors, it also means stock rebounds could be on the way. Enbridge and Air Canada are just two stocks due for a recovery — and a healthy economy can help facilitate that.

These investors should be sure to keep an eye on these two stocks and other top TSX gainers going forward.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Jared Seguin has no position in any of the stocks mentioned. The Motley Fool owns shares of and recommends Enbridge.

More on Investing

edit Person using calculator next to charts and graphs
Dividend Stocks

The Best Stocks to Invest $2,000 in Right Now

Do you have some extra cash to invest this month? Here are two value-priced dividend stocks to buy for a…

Read more »

Shopping card with boxes labelled REITs, ETFs, Bonds, Stocks
Dividend Stocks

TFSA: Can You Really Invest $95,000 Tax-Free?

You can, in fact, hold TSX stocks like Alimentation Couche-Tard Inc (TSX:ATD) tax-free in a TFSA. But can you hold…

Read more »

young woman celebrating a victory while working with mobile phone in the office
Investing

TFSA: 4 Canadian Stocks to Buy and Hold Forever

TFSA investors can expect to generate above-average capital gains from these fundamentally strong Canadian stocks.

Read more »

TFSA (Tax free savings account) acronym on wooden cubes on the background of stacks of coins
Dividend Stocks

TFSA Investors: 3 Stocks to Turbo-Charge Your Tax-Free Portfolio

The TFSA contribution room can be a significant constraint, and the most practical way to circumvent it is to choose…

Read more »

Two senior friends playing beat tennis on sand tennis court
Retirement

Retirees: What Is the CPP Enhancement and How to Use it

The CPP benefit might mean taking a cut from your paycheque now, but it means a far larger paycheque down…

Read more »

Various Canadian dollars in gray pants pocket
Investing

3 No-Brainer TSX Stocks Under $50

These TSX stocks are trading under $50 but have promising growth potential and can consistently deliver profits.

Read more »

Cogs turning against each other
Dividend Stocks

Invest $15,000 in This Dividend Stock for $108.26 in Monthly Passive Income

Monthly passive income stocks can give you far more than annual returns, but dividend income that can be reinvested time…

Read more »

Business success with growing, rising charts and businessman in background
Dividend Stocks

RBC Stock’s Path to Doubling Your Investment: A Decade-Long Perspective

The Royal Bank of Canada (TSX:RY) or RBC stock has more than doubled investors' capital in 10 years and may…

Read more »